For the Inventor, By the Inventor

Enter assignee name

Dibra S.p.a.

USPTO Granted Patents = 65

CIPO Patents = 1

Forward Citations = 510

Loading Chart...

Loading Chart...

63 inventors (with patents filed for the assignee):

Giorgio Ripa (22 out of 26 patents)

Fulvio Uggeri (15 out of 59 patents)

Marcella Murru (13 out of 14 patents)

4. Carlo Felice Viscardi (12 out of 20 patents)

5. Pier Lucio Anelli (11 out of 30 patents)

6. Maria Argese (11 out of 24 patents)

7. Christoph De Haen (11 out of 13 patents)

8. Marina Ausonio (11 out of 12 patents)

9. Alessandro Scala (10 out of 10 patents)

10. Marino Brocchetta (9 out of 18 patents)

11. Luigia Gozzini (9 out of 11 patents)

12. Mario Virtuani (7 out of 9 patents)

13. Franco Fedeli (7 out of 11 patents)

14. Vittorio Valle (5 out of 6 patents)

15. Monica Muttoni (5 out of 5 patents)

Core Competencies:

Diagnostic Imaging

Contrast Agents

Chelating Agents

Macrocyclic Compounds

Paramagnetic Chelates

MRI

Polychelants

Iodinated Contrast

Dendrimers

Metal Complexes

Aqueous Formulations

65 patents: Sort by Forward Citations

1. 6719958 - Polychelants, their complexes with metal ions, their preparation and their uses (2004-04-13),

2. 6458337 - Diagnostic imaging contrast agent with improved in serum relaxivity (2002-10-01),

3. 6432306 - Device for the deionization of substances that are not stable at acidic pH (2002-08-13),

4. 6417354 - 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid (2002-07-09),

5. 6403055 - Diagnostic imaging contrast agent with improved in serum relaxivity (2002-06-11),

6. 6342597 - 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents (2002-01-29),

7. 6337064 - Manganese chelates with high relaxivity in serum (2002-01-08),

8. 6262303 - Process for the preparation of S-N,N′-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)-amino]-2,4,6-triiodo-1,3-benzenedicarboxamide (2001-07-17),

9. 6187826 - Device and method for the regeneration of mixed ion exchange resin beds (2001-02-13),

10. 6177562 - Chelated complexes of paramagnetic metals with low toxicity (2001-01-23),

11. 6166201 - Process for the preparation of (2000-12-26),

12. 6162947 - Process for the preparation of 4-carboxy-5, 8,11-tris (2000-12-19),

13. 6162912 - Process of preparing tetraacetic acid derivatives (2000-12-18),

14. 616291 - Process of preparing tetraacetic acid derivatives (2000-12-19),

15. 6150520 - Process for the preparation of tetraazamacrocycles (2000-11-21),

Company Overview

Dibra S.p.a., headquartered in Milan, Italy, specializes in the development and manufacturing of advanced diagnostic imaging solutions. The company focuses on innovative technologies related to contrast agents and chelating agents, particularly in the fields of MRI and other imaging modalities. With expertise in macrocyclic compounds and paramagnetic chelates, Dibra is committed to enhancing diagnostic accuracy and patient safety through its cutting-edge products, contributing significantly to the medical imaging landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

65 Patents

#37 in Milan

#139 in Italy

#11,332 in the World

Dibra S.p.a.

Forward Citations = 510

63 inventors:

Giorgio Ripa (22 out of 26 patents)

Fulvio Uggeri (15 out of 59 patents)

Marcella Murru (13 out of 14 patents)

4. Carlo Felice Viscardi (12 out of 20 patents)

5. Pier Lucio Anelli (11 out of 30 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dibra S.p.a.. Retrieved from https://idiyas.com/company/dibra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…